Company page

Ose Immunotherapeutics Sa

Ose Immunotherapeutics Sa is a public company listed on the French market under the ticker OSE, with a market capitalization of approximately €93 million. The company focuses on developing innovative immunotherapies for cancer and autoimmune diseases. Ose Immunotherapeutics aims to address unmet medical needs through its advanced therapeutic candidates.

profileOSE:EURONEXTAI content: aiUpdated June 24, 2026/company/ose-immunotherapeutics-sa/c-xml230wh
Ose Immunotherapeutics Sa logo
Ticker
OSE:EURONEXT
Asset type
Stock
Market cap
$93.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR